Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy (POPSTAR II)
NCT 05560659 Brief Summary The aim of this study is to assess…
Read more arrow_forwardNCT 05560659 Brief Summary The aim of this study is to assess…
Read more arrow_forwardACTRN 12623000096651 Brief Summary This study aims to evaluate a new approach…
Read more arrow_forwardNCT 06604533 Brief Summary The aim of this study is to investigate…
Read more arrow_forwardACTRN 12622000410752 Brief Summary Traditionally, combination therapy has not proven to be…
Read more arrow_forwardNCT 06097728 Brief Summary This is a phase III, randomized, open-label, multicenter,…
Read more arrow_forwardNCT 05286788 Brief Summary MEKTOVI (binimetinib) is an oral, highly selective…
Read more arrow_forwardNCT 03860883 Brief Summary Patients with a primary invasive melanoma are recommended…
Read more arrow_forwardACTRN 12622001158752 Brief Summary This clinical trial aims to assess the effect…
Read more arrow_forwardNCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 02645149 Brief Summary This is a patient oriented translational research project…
Read more arrow_forward